Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.
Fiche publication
Date publication
avril 2021
Journal
Lung
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel
Tous les auteurs :
Arndt AT, Brunelli A, Cicconi S, Falcoz PE, Salati M, Kozower B, Liptay MJ, Rocco G, Karush JM, Geissen N, Basu S, Seder CW
Lien Pubmed
Résumé
Management of clinical stage IIIA-N2 (cIIIA-N2) non-small cell lung cancer (NSCLC) remains controversial. We evaluated treatment strategies and outcomes in cIIIA-N2 NSCLC patients who underwent pulmonary resection in The Society of Thoracic Surgeons General Thoracic Surgery Database (STS GTSD) and the European Society of Thoracic Surgeons (ESTS) Registry.
Référence
Lung. 2021 Apr 28;: